Methylphenidate Hydrochloride 72865-0122-01
- Manufacturer
- Xlcare Pharmaceuticals Inc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- February 26, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA207416
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methylphenidate Hydrochloride | 5 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
72865-0122-01Selected100 TABLET in 1 BOTTLE (72865-122-01)
Other packages for this product(1)
500 TABLET in 1 BOTTLE (72865-122-05)